文献速递食管与纵隔外科

I期胸腺瘤部分与全胸腺切除术肿瘤学结局比较

Comparison of Oncologic Outcomes After Partial and Total Thymectomy for Stage I Thymomas.
PubMed 文献 · Ann Thorac Surg · 2025-11-24

基于国际胸腺恶性肿瘤兴趣组2000-2014年回顾性数据库,纳入692例无重症肌无力的I期胸腺瘤患者,比较部分胸腺切除术(PT,158例)与全胸腺切除术(TT,534例)的肿瘤学结局。PT在可实现R0切除的I期胸腺瘤中或可考虑。

要点

  • I期无重症肌无力胸腺瘤中,PT与TT的无复发生存和总生存无统计学差异。
  • PT组新发重症肌无力与TT组无差异。
  • PT可用于R0切除可合理实现的I期胸腺瘤。

核心结论

  • 对于无重症肌无力的I期胸腺瘤,部分胸腺切除术与全胸腺切除术的复发和生存结局在统计学上相似,且新发重症肌无力无差异。
  • 结果支持在可合理实现R0切除的I期胸腺瘤中考虑部分胸腺切除术。

研究设计与样本

  • 回顾性数据库研究,查询国际胸腺恶性肿瘤兴趣组2000至2014年数据库。
  • 纳入692例无重症肌无力的I期胸腺瘤患者,其中部分胸腺切除术158例(23%),全胸腺切除术534例(77%)。
  • 采用逆概率权重校正患者因素对全胸腺切除术的预测,无复发生存按年龄和T分期(1a vs 1b)加权。

主要发现

  • 部分胸腺切除术组患者更年轻且体能状态更好,R0切除率和组织学类型与全胸腺切除术组相似。
  • 部分胸腺切除术组T1b胸腺瘤更多,辅助化疗和放疗更频繁。
  • 两组新发重症肌无力无差异。

临床怎么用

  • 对于无重症肌无力的I期胸腺瘤,当R0切除可合理实现时,可考虑部分胸腺切除术。
  • 行部分胸腺切除术的外科医生应报告其结局以继续相关讨论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total thymectomy (TT) has been the standard treatment for thymoma. However, many thymomas may be amenable to partial thymectomy (PT), which can achieve similar R0 resection frequency with favorable perioperative outcomes. We sought to determine whether PT results in oncologic outcomes similar to TT for noninvasive thymomas. METHODS: We queried the International Thymic Malignancy Interest Group retrospective database from 2000 to 2014 for patients with stage I thymomas without myasthenia gravis undergoing TT or PT. Outcomes were freedom from recurrence (weighted for age and T category 1a vs 1b) and overall survival, with inverse probability weights of patient factors as predictors of TT. RESULTS: Included were 692 patients, with 158 PT (23%) and 534 TT (77%). PT patients were younger with better performance status. R0 resection and histology were similar. The PT group had more T1b thymomas. Adjuvant chemotherapy and radiotherapy were more frequent after PT. There was no difference in new-onset myasthenia gravis. Weighted freedom from recurrence (hazard ratio, 1.09; P = .81) and overall survival (hazard ratio, 0.62; P = .11) was similar for PT compared with TT. CONCLUSIONS: PT for stage I thymomas without myasthenia resulted in statistically similar recurrence and survival, and no difference in the development of new-onset myasthenia gravis, compared with TT. These results add to a growing body of literature around PT, suggesting it may be considered for stage I thymomas when R0 resection can reasonably be achieved. Surgeons performing PT are encouraged to report their outcomes to continue this discussion.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Campbell JM, Chansky K, Fang W, et al. Comparison of Oncologic Outcomes After Partial and Total Thymectomy for Stage I Thymomas. Ann Thorac Surg. 2025. PMID: 41297576. doi:10.1016/j.athoracsur.2025.11.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。